Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.

作者: Minjing Zou , Essa Y. Baitei , Ali S. Alzahrani , Futwan Al-Mohanna , Nadir R. Farid

DOI: 10.1593/NEO.81044

关键词:

摘要: Activating BRAF mutations have been reported in 40% of papillary thyroid carcinomas (PTCs). The involvement pseudogene tumorigenesis has not previously studied. We investigated expression 68 tumors: 16 multinodular goiters, 43 classic PTCs, 6 follicular variants PTC, and 3 anaplastic carcinomas. function was studied by Western blots, soft agar assay, nude mice. detected 7 18 1 PTC. There is an inverse correlation between mutation. transcripts were more frequently tumors without mutation than those with Furthermore, could activate the MAP kinase signaling pathway, transform NIH3T3 cells vitro, induce These data suggest that activation may play a role tumor development.

参考文章(34)
F Apiou, Alain Eychène, B. Dutrillaux, Georges Calothy, Jean-Vianney Barnier, Chromosomal assignment of two human B-raf(Rmil) proto-oncogene loci: B-raf-1 encoding the p94Braf/Rmil and B-raf-2, a processed pseudogene. Oncogene. ,vol. 7, pp. 1657- 1660 ,(1992)
Holger Thiele, Mario Berger, Angela Skalweit, Bernd-Joachim Thiele, Expression of the gene and processed pseudogenes encoding the human and rabbit translationally controlled tumour protein (TCTP). FEBS Journal. ,vol. 267, pp. 5473- 5481 ,(2000) , 10.1046/J.1432-1327.2000.01609.X
Kenneth B. Ain, Paolo Gattuso, Xiulong Xu, Richard A. Prinz, Roderick M. Quiros, High Prevalence of BRAF Gene Mutation in Papillary Thyroid Carcinomas and Thyroid Tumor Cell Lines Cancer Research. ,vol. 63, pp. 4561- 4567 ,(2003)
Edna T Kimura, Marina N Nikiforova, Zhaowen Zhu, Jeffrey A Knauf, Yuri E Nikiforov, James A Fagin, None, High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research. ,vol. 63, pp. 1454- 1457 ,(2003)
Carolyn J. Brown, John M. Greally, A stain upon the silence: genes escaping X inactivation Trends in Genetics. ,vol. 19, pp. 432- 438 ,(2003) , 10.1016/S0168-9525(03)00177-X
Oliver H. Tam, Alexei A. Aravin, Paula Stein, Angelique Girard, Elizabeth P. Murchison, Sihem Cheloufi, Emily Hodges, Martin Anger, Ravi Sachidanandam, Richard M. Schultz, Gregory J. Hannon, Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes Nature. ,vol. 453, pp. 534- 538 ,(2008) , 10.1038/NATURE06904
C.M. Disteche, G.N. Filippova, K.D. Tsuchiya, Escape from X inactivation. Cytogenetic and Genome Research. ,vol. 99, pp. 36- 43 ,(2002) , 10.1159/000071572
Scott A. Hundahl, Irvin D. Fleming, Amy M. Fremgen, Herman R. Menck, A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 Cancer. ,vol. 83, pp. 2638- 2648 ,(1998) , 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1
Evgeniy S. Balakirev, Francisco J. Ayala, Pseudogenes: are they "junk" or functional DNA? Annual Review of Genetics. ,vol. 37, pp. 123- 151 ,(2003) , 10.1146/ANNUREV.GENET.37.040103.103949
Huira Chong, Kun-Liang Guan, None, Regulation of Raf through phosphorylation and N terminus-C terminus interaction. Journal of Biological Chemistry. ,vol. 278, pp. 36269- 36276 ,(2003) , 10.1074/JBC.M212803200